z-logo
open-access-imgOpen Access
miR-4262, low level of which predicts poor prognosis, targets proto-oncogene CD163 to suppress cell proliferation and invasion in gastric cancer
Author(s) -
Hongzhi Zhang,
Huijuan Jiang,
Huixiang Zhang,
Juncai Liu,
Xiaoyi Hu,
Lei Chen
Publication year - 2019
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s187881
Subject(s) - medicine , cancer , oncogene , cell growth , apoptosis , cancer cell , carcinoma , cell , cancer research , pathology , biology , cell cycle , biochemistry , genetics
miR-4262 was identified as a tumor promoter in several cancers, but its exact role in gastric carcinoma is still largely unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here